BNP outperformed ANP and N-terminal ANP as a diagnostic marker for left ventricular systolic dysfunction, diastolic dysfunction, and ventricular hypertrophy.
Triple detection superiorityBNP outperformed ANP-based markers for systolic dysfunction, diastolic dysfunction, AND ventricular hypertrophy
What the researchers found
BNP was superior to both C-terminal ANP and N-terminal ANP for detecting left ventricular systolic dysfunction, diastolic dysfunction, and ventricular hypertrophy.
Why it matters
Having a single blood test that can detect multiple types of heart problems enables efficient screening and early intervention, potentially saving lives through earlier treatment.
How the study worked
Cross-sectional study comparing plasma levels of BNP, C-terminal ANP, and N-terminal ANP as diagnostic markers across three types of cardiac dysfunction.
What this study cannot tell us
Cross-sectional design; specific thresholds and sensitivity/specificity values not detailed in abstract. Patient population characteristics not described.
How to read the evidence
Moderate clinical evidence from a direct comparison study. Strong diagnostic findings that have been confirmed by subsequent large-scale studies.
When this study was published
Published in 1996, this landmark comparison study contributed to BNP becoming the standard cardiac biomarker worldwide.
The bigger picture
This study was instrumental in establishing BNP as the preferred cardiac natriuretic peptide biomarker, leading to its widespread clinical adoption worldwide.
Questions still open
- What BNP cutoff values optimize detection of each type of cardiac dysfunction?
- Can BNP alone replace echocardiography for screening?
Common questions
Why is BNP better than ANP for heart testing?
What is the difference between systolic and diastolic dysfunction?
Read the original research
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Hypertension (Dallas, Tex. : 1979), 28(6), 988-94
Citation
Yamamoto, K; Burnett, J C; Jougasaki, M; Nishimura, R A; Bailey, K R; Saito, Y; Nakao, K; Redfield, M M. (1996). Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.. Hypertension (Dallas, Tex. : 1979), 28(6), 988-94.